Philips CPAP Lawsuit 2026: The Recall, the $1.1B Settlement & Who Still Qualifies to File
The Philips CPAP lawsuit grew out of a June 2021 recall of roughly 15 million sleep-apnea devices after foam was found to break down into particles users could inhale. Philips agreed in April 2024 to a $1.075 billion personal-injury settlement, but both settlement programs are closed to new claims. In 2026, only individual claims remain, each governed by its state's filing deadline.
Key facts
- On June 14, 2021, Philips Respironics recalled about 15 million CPAP, BiPAP, and ventilator devices worldwide after PE-PUR sound-reduction foam was found to degrade into inhalable particles.
- The federal cases were consolidated in October 2021 as MDL 3014 before Senior Judge Joy Flowers Conti in the Western District of Pennsylvania.
- In September 2023, Philips agreed to a $479 million economic-loss settlement for people who paid for, leased, or were prescribed recalled devices.
- On April 29, 2024, Philips agreed to a $1.075 billion personal-injury settlement plus a $25 million medical-monitoring fund; registration closed January 31, 2025, and the claim deadline passed March 7, 2026.
- Also in April 2024, a federal consent decree barred Philips from selling new CPAP devices in the U.S. until it completes an FDA-supervised remediation plan.
The Recall That Started Everything
PE-PUR foam is a polyester-based polyurethane foam Philips placed inside its breathing devices to muffle sound and vibration. In June 2021 the company disclosed that the foam could degrade, crumbling into particles and releasing chemicals into the air pathway users breathed through each night.
The FDA classed it a Class I recall — its most serious category — covering roughly 15 million machines worldwide: first-generation DreamStation CPAP and BiPAP machines, the DreamStation Go, certain SystemOne models, and ventilators such as the E30 and Trilogy 100/200. Adverse-event trackers later counted more than 116,000 FDA reports tied to the foam, including 561 death reports — allegations, not proof of causation.
How the Litigation Was Organized
An MDL, or multidistrict litigation, gathers similar federal lawsuits before one judge for efficient pretrial work while each case remains its own claim. On October 8, 2021, the federal panel created MDL 3014 in Pittsburgh, gathering thousands of claims for injury, economic loss, and medical monitoring.
The pattern is familiar — a sweeping device recall, centralized litigation, parallel class settlements, and a long tail of individual cases. The Exactech implant recall litigation followed a similar consolidation arc after defective packaging compromised its devices.
The $1.075 Billion Personal-Injury Settlement
On April 29, 2024, Philips agreed to a $1.075 billion personal-injury settlement — $1.05 billion for the settlement fund, $25 million for administration, and a separate $25 million for medical monitoring. Philips later disclosed that over 95 percent of eligible claimants registered, and the deal became final in February 2025.
The economic side had settled earlier: a September 2023 agreement worth $479 million paid device owners and payers through device payment awards, a $100 device-return award, replacement awards, and a $34 million payer fund; its filing deadline was August 9, 2024, and it is closed.
Individual awards were set by a private claims matrix, and Philips has published no per-person figures. Compensation varies widely by case — most individual awards are confidential, so no reliable public per-case figures exist.
The Consent Decree That Froze the Business
That same April, a federal court entered a consent decree requiring a recall-remediation plan under outside experts' watch and barring new U.S. CPAP sales until the FDA gives written clearance. The decree resolved allegations only; it contains no determination of liability.
The business fallout was severe: Philips shares lost roughly two-thirds of their value around the 2021 recall, and rivals absorbed its market share. In October 2026 a Dutch court dismissed shareholders' demand for a formal inquiry, while French prosecutors and U.S. authorities continue their own probes; a return to normal U.S. sales remains a long, compliance-heavy road.
Where the Case Stands in October 2026
The headline settlements did not end the litigation. As of mid-2026, roughly 619 cases remained active in MDL 3014 — plaintiffs who did not settle and are still pursuing them. Bellwether trials were projected for late 2026; in January 2026 Judge Conti remanded one CPAP cancer case to Kentucky state court, and payments to approved claimants began flowing in 2026.
The long tail has a medical logic: injuries like cancer or lung fibrosis can surface years after exposure, and users ran their machines eight or more hours a night — which is why the AFFF firefighting-foam cases carry their own medical-monitoring component.
Who Can Still File — and How to Protect a Claim
Every settlement window is closed: economic loss (August 9, 2024), personal-injury registration (January 31, 2025), and the personal-injury claim deadline (March 7, 2026). What remains is an individual product-liability lawsuit, whose deadline comes from state law, not from any settlement program. Some states start the clock at diagnosis rather than first device use, and missing that deadline can end an otherwise valid claim — so anyone with a qualifying injury should consult a lawyer promptly. You can follow the remaining court milestones on our Problem Solved channel; the 3M earplug litigation shows how claimants are handled once a mass-tort settlement window closes.
A qualified attorney will ask for this evidence, so preserve it now:
- The device's serial number, plus any recall-registration confirmation
- Purchase, lease, or rental records showing when and where the device was obtained
- Medical records documenting the diagnosis, its date, and all treatment received
- Photographs of the device, including any visible signs of foam degradation
- Any communications with Philips, a provider, or an equipment supplier
- Insurance or Medicare/Medicaid documentation relevant to liens on any recovery
This article is general information, not legal advice; a qualified attorney should evaluate your individual situation.
Who Benefits From This — and Who Does Not
The Philips CPAP lawsuit grew out of a June 2021 recall of roughly 15 million sleep-apnea devices after foam was found to break down into particles users could inhale. Philips agreed in April 2024 to a $1.075 billion personal-injury settlement, but both settlement programs are closed to new claims. In 2026, only individual claims remain, each governed by its state filing deadline. This guide helps some readers act while a path is still open — and warns others not to wait for settlement money that is no longer available.
Who benefits:
- Users of a recalled device with a documented injury — check your device with Philips' serial-number tool, then discuss an individual action with an attorney while your state's deadline still runs.
- Plaintiffs already active in MDL 3014 — about 619 cases remained active, with bellwether trials scheduled for late 2026: following that process remains their main path.
- Readers who want to know what is still possible — an individual action remains possible if the statute of limitations has not expired, even though the settlement programs are closed.
Who does not benefit:
- Anyone hoping for settlement-program money without registering — registration closed January 31, 2025 and the claims deadline passed March 7, 2026: unregistered claimants cannot be paid from those programs.
- Anyone who never owned a recalled device — the litigation covers only owners of devices in the recall of roughly 15 million machines.
- Anyone whose state deadline has expired — each state sets its own filing deadline, and an expired deadline closes the individual-action path.
Related reading: Whittaker $535 Million Talc Settlement Approved 2026.
FAQ
Is the Philips CPAP lawsuit still open in 2026?
Yes, in part. Both settlement programs are closed, but MDL 3014 continues with roughly 619 active non-settling cases, bellwether trials were projected for late 2026; new individual lawsuits remain possible where a state's filing deadline has not yet expired.
Can I still get money from the $1.075 billion settlement?
No, if you never registered. Registration closed January 31, 2025, and the claim deadline passed March 7, 2026. Registered claimants are paid through the program administrator; anyone who missed the deadlines must discuss an individual lawsuit with an attorney.
Which devices were actually recalled?
About 15 million machines: first-generation DreamStation CPAP and BiPAP machines, the DreamStation Go, certain SystemOne models, and ventilators such as the E30 and Trilogy 100/200. Owners could check eligibility via Philips' serial-number lookup.
What injuries were linked to the degrading foam?
Plaintiffs alleged cancer, respiratory damage, airway inflammation and irritation, headaches, hypersensitivity reactions, and nausea or vomiting from inhaling foam particles or off-gassed chemicals. Philips has cited third-party studies finding no consistent statistical link to cancer, and no jury verdict has decided individual causation.
Do I need my device's serial number to pursue a claim?
It helps substantially: the serial number proves you owned a recalled device and ties your claim to the recall population. If you lost it, contact the retailer or supplier that sold you the machine.
Who can no longer benefit from the Philips CPAP settlement?
Anyone who never registered for the settlement programs: registration closed January 31, 2025 and the claims deadline passed March 7, 2026, so unregistered claimants cannot receive money from the $1.075 billion settlement. Their remaining option, if the state deadline still runs, is an individual action.